Literature DB >> 6609951

Adrenogenital syndrome due to 11-beta-hydroxylase deficiency with skeletal abnormalities and pulmonary stenosis.

K Ajlouni, M El-Zaheri, M Habbab, Y Qoussous, M El-Khateeb.   

Abstract

This report describes a 13-year-old female patient with 11-beta-hydroxylase deficiency who was found to have short fourth metatarsals and pulmonary stenosis. The unusual association between these abnormalities and this rare form of congenital adrenal hyperplasia is presented.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6609951     DOI： 10.1007/bf03348402

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  6 in total

1.  Deoxycorticosterone excretion in normal, hypertensive and hypokalaemic subjects.

Authors:  C L Cope; S Loizou
Journal:  Clin Sci Mol Med       Date:  1975-02

2.  Clinical and metabolic variations in the adrenogenital syndrome.

Authors:  A M BONGIOVANNI; W R EBERLEIN
Journal:  Pediatrics       Date:  1955-11       Impact factor: 7.124

3.  Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility.

Authors:  G J Klingensmith; S C Garcia; H W Jones; C J Migeon; R M Blizzard
Journal:  J Pediatr       Date:  1977-06       Impact factor: 4.406

4.  Simplification of urinary aldosterone measurement by radioimmunoassay.

Authors:  C L Cope; S Loizou
Journal:  J Clin Pathol       Date:  1973-08       Impact factor: 3.411

5.  Measurement of plasma aldosterone by radioimmunoassay.

Authors:  F Bayard; I Z Beitins; A Kowarski; C J Migeon
Journal:  J Clin Endocrinol Metab       Date:  1970-07       Impact factor: 5.958

6.  Congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency: final diagnosis in adult age in three patients.

Authors:  A Glenthøj; M D Nielsen; J Starup
Journal:  Acta Endocrinol (Copenh)       Date:  1980-01
  6 in total
  1 in total

1.  Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency with skeletal abnormalities.

Authors:  K M Ajlouni; M A Arnaout; Y Qoussous
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.